MICHELLE MUNSON: Open Payments
NPI 1912360181 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 17 payments from 9 companies in 2025. Trend: 2023 $1,475 · 2024 $1,189 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $105 |
| GENZYME CORPORATION | 3 | $90 |
| PFIZER INC. | 2 | $52 |
| Amgen Inc. | 2 | $50 |
| Genentech USA, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: TEZSPIRE, DUPIXENT, EUCRISA, FASENRA, Xolair, TRELEGY ELLIPTA, Cologuard Collection Kit, Ohtuvayre.
Industry payments across MD — which companies pay providers there.
